A vaccination programme to tackle respiratory syncytial virus (RSV) is to be extended to cover premature babies born in Northern Ireland.
A long-acting injection is to be offered for eligible children from this autumn.
RSV is a common, but highly infectious, respiratory virus that affects the breathing system, particularly in young children and older adults.
It infects 90% of children by the age of two and is one of the leading causes of hospitalisation in the first year of life.
